Physician profile
Richa Gupta
NPI 1649541061
$46,485.03
in general payments reported to CMS, 2019-2025
9 companies · $17K in 2025
The $17K reported for 2025 was more than what 83% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $46.33 · 2021: $27.95 · 2022: $284 · 2023: $4,034 · 2024: $25K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Food and Beverage: $7,646 · Travel and Lodging: $6,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,000.00 |
| Food and Beverage | $7,646.08 |
| Travel and Lodging | $6,230.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $42,671.82 | 2023-2025 | Barostim Neo System |
| Abbott Laboratories | $2,470.85 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Thoratec Heartmate II, Lvas Implant Kit, Cardiomems |
| Abiomed | $467.52 | 2019-2024 | Impella |
| Ancora Heart, INC. | $279.40 | 2025 | Accucinch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.08 | 2020-2025 | Lifevest |
| Novo Nordisk INC | $144.70 | 2024 | Wegovy |
| Medtronic, INC. | $129.97 | 2023 | Linq II |
| Janssen Pharmaceuticals, INC | $105.31 | 2019 | |
| Kestra Medical Technology Services, INC. | $62.38 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richa Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.